Skip to main content
Clinical Trials/NCT02264782
NCT02264782CompletedNot Applicable

PreView: The Preventive Video Education in Waiting Rooms Program

University of California, San Francisco2 sites in 1 country508 target enrollmentStarted: July 1, 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
508
Locations
2
Primary Endpoint
Increasing rates of breast, cervical and colorectal cancer screening

Study Overview

Brief Summary

This clinical trial studies how well PreView, preventive video education, works in increasing rates of breast, cervical and colorectal cancer screening, improving participants' stage of change with respect to age appropriate cancer screening and increasing patient-provider discussions about prostate cancer screening.

Detailed Description

PRIMARY OBJECTIVES:

I. To determine the extent to which PreView increases the likelihood that primary care patient participants will receive mammograms, pap tests, colon cancer tests or prostate specific antigen (PSA) testing discussions with primary care physicians compared with participants who receive usual care.

II. To determine the extent that PreView increases participants' readiness to be screened for breast cancer, cervical cancer or colorectal cancer (CRC) compared with usual care.

III. To determine the extent that PreView increases the likelihood that PSA testing will be discussed in primary care physician visits compared with usual care.

OUTLINE: Patients are randomized into 1 of 2 groups.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Screening
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
50 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Without a history of cancer

Exclusion Criteria

  • •With a history of cancer (for whom subsequent procedures would be surveillance and not screening)
  • •Individuals who do not speak English or Spanish (except for the testimonials)

Arms & Interventions

Group I (PreView)

Experimental

Patients complete PreView, the Video Doctor plus Provider Alert, over 45 minutes on an iPad in the waiting room before a doctor visit.

Intervention: Computer-Assisted Intervention (Other)

Group I (PreView)

Experimental

Patients complete PreView, the Video Doctor plus Provider Alert, over 45 minutes on an iPad in the waiting room before a doctor visit.

Intervention: Questionnaire Administration (Other)

Group II (educational video)

Active Comparator

Patients watch a video about healthy lifestyles including information about exercise and healthy eating over 45 minutes on an iPad in the waiting room before a doctor visit.

Intervention: Computer-Assisted Intervention (Other)

Group II (educational video)

Active Comparator

Patients watch a video about healthy lifestyles including information about exercise and healthy eating over 45 minutes on an iPad in the waiting room before a doctor visit.

Intervention: Questionnaire Administration (Other)

Outcomes

Primary Outcomes

Increasing rates of breast, cervical and colorectal cancer screening

Time Frame: From Baseline up to 14 months

To determine the extent that PreView increases the likelihood that PSA testing will be discussed in primary care physician visits compared with usual care.

Changing participants' readiness to be screened for breast, cervical and colorectal cancer

Time Frame: Up to 3 hours from pre-visit to post-visit interview.

To determine the extent to which PreView increases the likelihood that primary care patient participants will receive mammograms, Pap tests, colon cancer tests or PSA testing discussions with primary care physicians compared with participants who receive usual care

Increasing physician-patient discussions about PSA screening measured by chart review

Time Frame: Baseline up to 14 months

To determine the extent that PreView increases participants' readiness to be screened for breast cancer, cervical cancer or CRC compared with usual care.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials